Old Well Partners’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Old Well Partners’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-984	Closed	-$84K	–	52
2020 Q3	$84K	Sell	984 -476	-33%	-$55.5K	0.08%	33
2020 Q2	$136K	Sell	1,460 -1,457	-50%	-$80.3K	0.11%	24
2020 Q1	$83K	Sell	2,917 -727	-20%	-$28.3K	0.08%	26
2019 Q4	$151K	Buy	+3,644	New	+$79.8K	0.12%	27

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Old Well Partners's VBIV Position: Q4 2020 in Review

Old Well Partners sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2020, closing a stake of 984 shares — an estimated $84K sold.

Old Well Partners first reported a position in VBIV in Q4 2019 and held it in 4 quarters. The position peaked at $151K in Q4 2019. 122 funds tracked by Wall St. Rank hold VBIV as of Q4 2020.

Old Well Partners reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2020 after selling out during the quarter.
Old Well Partners sold 984 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2020, an estimated $84K.
Old Well Partners first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2019 and held it in 4 quarters.
Old Well Partners's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $151K in Q4 2019.
122 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2020.

Based on Old Well Partners's 13F filing for Q4 2020, filed 16 Feb 2021.